Boston Life Sciences

Boston Life Sciences, Inc (NASDAQ: BLSI) is a biotechnology company engaged in the research and development of biopharmaceutical products for the diagnosis and treatment of Central Nervous System disorders. Our energy and focus in this area are reflected in several important initiatives. Our molecular imaging program has a product candidate, the ALTROPANE® molecular imaging agent, in phase 3 clinical development. ALTROPANE® is a diagnostic tool intended to aid in differentiating Parkinsonian tremors from non-Parkinsonian or Essential Tremor. ALTROPANE is also being assessed in Phase II trials for diagnosing ADHD. Through our licensing and research collaboration with Children's Hospital Boston, Boston Life Sciences maintains a world-class position in the field of regenerating nerve axons. Our sponsored scientific research in this ground-breaking technology may someday make possible therapies leading to functional recovery following stroke, spinal cord and ocular injuries. Finally, our program in Parkinson’s Disease aims to provide a therapeutic solution to managing the symptoms as well as to slowing the progression of the disease.

Contact Details: 85 Main Street Hopkinton 01748 United States of America Tel: (508) 497-2360 Fax: (508) 497-9964 Email: IR@bostonlifesciences.com WWW: www.bostonlifesciences.com/

BioNews Results for Boston Life Sciences:
BIND Biosciences, Co-Founder Selected as 2009 Mass High Tech All-Star for Contributions in Life Sciences	Azonano:  Oct 30 2009 3:44AM Matching: boston life sciences
Identifying molecules in infrared could lead to new medicines	Research & Development:  Oct 29 2009 2:10PM Matching: boston life sciences
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News	Xconomy:  Oct 28 2009 5:02AM Matching: boston life sciences
European Biotech Company Biocell Center Opens First U.S. Facility for Preservation of Amniotic Stem Cells in M	PR Newswire:  Oct 28 2009 12:17PM Matching: boston life sciences
Why is Pharma Betting So Big on Innovation in Boston?	Xconomy:  Oct 27 2009 1:34PM Matching: boston life sciences
Promote your company here: BioNewsCast - Press Release Distribution	→View more Boston Life Sciences news.

Boston Life Sciences Clinical Trials:
A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

Boston Life Sciences Patents:
US Patent No.	Title
7078385	Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
6586401	Troponin subunit I fragment and homologs thereof
6465431	Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis

Boston Life Sciences (BLSI) Financial information Links from Barchart
BLSI Quote from from Barchart.com
BLSI Chart from from Barchart.com
BLSI Profile from from Barchart.com
BLSI Opinion from from Barchart.com
→View more Boston Life Sciences finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 961 times since April 2007, the link to the organisation's website has been followed 196 times

Recent Search Terms used to find this page: natick ma life science company | boston area life science companies | life science companies boston | boston life sciences | boston life sciences | life sciences company in boston | life sciences research firm boston | life sciences companies massachusetts boston | Boston Life Science | life science company Boston Reilly | .

Search for more companies in Hopkinton

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Boston Life Sciences